214 related articles for article (PubMed ID: 10861195)
21. Serologic response of pups to the low-passage, modified-live canine parvovirus-2 component in a combination vaccine.
O'Brien SE
J Am Vet Med Assoc; 1994 Apr; 204(8):1207-9. PubMed ID: 8014088
[TBL] [Abstract][Full Text] [Related]
22. Long-term viremia and fecal shedding in pups after modified-live canine parvovirus vaccination.
Decaro N; Crescenzo G; Desario C; Cavalli A; Losurdo M; Colaianni ML; Ventrella G; Rizzi S; Aulicino S; Lucente MS; Buonavoglia C
Vaccine; 2014 Jun; 32(30):3850-3. PubMed ID: 24793948
[TBL] [Abstract][Full Text] [Related]
23. Are licensed canine parvovirus (CPV2 and CPV2b) vaccines able to elicit protection against CPV2c subtype in puppies?: A systematic review of controlled clinical trials.
Hernández-Blanco B; Catala-López F
Vet Microbiol; 2015 Oct; 180(1-2):1-9. PubMed ID: 26249827
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
Litster A; Nichols J; Volpe A
Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of antibodies to canine parvovirus and reaction to vaccination in client-owned, healthy dogs.
Riedl M; Truyen U; Reese S; Hartmann K
Vet Rec; 2015 Dec; 177(23):597. PubMed ID: 26514756
[TBL] [Abstract][Full Text] [Related]
26. Serologic response of captive coyotes (Canis latrans Say) to canine parvovirus and accompanying profiles of canine coronavirus titers.
Green JS; Bruss ML; Evermann JF; Bergstrom PK
J Wildl Dis; 1984 Jan; 20(1):6-11. PubMed ID: 6325726
[TBL] [Abstract][Full Text] [Related]
27. Are vaccine strain, type or administration protocol risk factors for canine parvovirus vaccine failure?
Altman KD; Kelman M; Ward MP
Vet Microbiol; 2017 Oct; 210():8-16. PubMed ID: 29103701
[TBL] [Abstract][Full Text] [Related]
28. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
[TBL] [Abstract][Full Text] [Related]
29. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
[TBL] [Abstract][Full Text] [Related]
30. Assessment of maternal antibody decay and response to canine parvovirus vaccination using a clinic-based enzyme-linked immunosorbent assay.
Waner T; Naveh A; Wudovsky I; Carmichael LE
J Vet Diagn Invest; 1996 Oct; 8(4):427-32. PubMed ID: 8953526
[TBL] [Abstract][Full Text] [Related]
31. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
[TBL] [Abstract][Full Text] [Related]
32. Occurrence of severe gastroenteritis in pups after canine parvovirus vaccine administration: a clinical and laboratory diagnostic dilemma.
Decaro N; Desario C; Elia G; Campolo M; Lorusso A; Mari V; Martella V; Buonavoglia C
Vaccine; 2007 Jan; 25(7):1161-6. PubMed ID: 17092616
[TBL] [Abstract][Full Text] [Related]
33. [Canine parvovirus: recent knowledge of the origin and development of a viral pathogen].
Truyen U
Tierarztl Prax; 1994 Dec; 22(6):579-84. PubMed ID: 7716757
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study.
Vila Nova B; Cunha E; Sepúlveda N; Oliveira M; São Braz B; Tavares L; Almeida V; Gil S
BMC Vet Res; 2018 Nov; 14(1):348. PubMed ID: 30445957
[TBL] [Abstract][Full Text] [Related]
35. Experiments with a homologous, inactivated canine parvovirus vaccine in vaccination programmers for dogs.
Wilson JH; Hermann-Dekkers WM
Vet Q; 1982; 4(3):108-16. PubMed ID: 6293155
[TBL] [Abstract][Full Text] [Related]
36. Molecular typing of canine parvovirus strains circulating from 2008 to 2012 in an organized kennel in India reveals the possibility of vaccination failure.
Mittal M; Chakravarti S; Mohapatra JK; Chug PK; Dubey R; Upmanuyu V; Narwal PS; Kumar A; Churamani CP; Kanwar NS
Infect Genet Evol; 2014 Apr; 23():1-6. PubMed ID: 24486948
[TBL] [Abstract][Full Text] [Related]
37. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
[TBL] [Abstract][Full Text] [Related]
38. Performance of high titre attenuated canine parvovirus vaccine in pups with maternally derived antibody.
Burtonboy S; Charlier P; Hertoghs J; Lobmann M; Wiseman A; Woods S
Vet Rec; 1991 Apr; 128(16):377-81. PubMed ID: 2053262
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of vaccination against canine parvovirus.
Thompson H
Vet Rec; 2006 Oct; 159(17):570-1; discussion 571. PubMed ID: 17056657
[No Abstract] [Full Text] [Related]
40. MT-PCR panel detection of canine parvovirus (CPV-2): Vaccine and wild-type CPV-2 can be difficult to differentiate in canine diagnostic fecal samples.
Meggiolaro MN; Ly A; Rysnik-Steck B; Silva C; Zhang J; Higgins DP; Muscatello G; Norris JM; Krockenberger M; Šlapeta J
Mol Cell Probes; 2017 Jun; 33():20-23. PubMed ID: 28254505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
